Abstract:The aminocoumarin antibiotics novobiocin, clorobiocin and coumermycin A1 are produced by different Streptomyces strains. They are potent inhibitors of bacterial gyrase and topoisomerase IV, and novobiocin has been licensed as antibiotic for clinical use (Albamycin®). They also have potential applications in oncology. The biosynthetic gene clusters of all three antibiotics have been cloned and sequenced, and the function of nearly all genes contained therein has been elucidated. Rapid and versatile methods have been developed for the heterologous expression of these biosynthetic gene clusters, and in Streptomyces coelicolor M512 as heterologous host these antibiotics were produced in yields comparable to those in the natural producer strains. λ RED-mediated homologous recombination was used for genetic modification of the gene clusters in Escherichia coli. The phage φC31 attachment site and integrase functions were introduced into the cosmid backbones and employed for stable integration of the clusters into the genome of the heterologous hosts. Modification of the clusters by single or multiple gene replacements or gene deletions resulted in the formation of numerous new aminocoumarin derivatives, providing an efficient tool for the rational generation of antibiotics with modified structure. Additionally, many new antibiotics were generated by mutasynthesis experiments, i.e. the targeted deletion of genes required for the biosynthesis of a certain structural moiety of the antibiotic, and the replacement of this moiety by structural analogs which were added to the culture broth. The diversity of new structures obtained by this approach could be expanded by further genetic modifications of the gene deletion mutants, especially by expression of heterologous biosynthetic enzymes with appropriate substrate specificity. Keywords: acyl carrier protein, Novobiocin, clorobiocin analogs, genetic manipulations, Streptomyces coelicolor

New Aminocoumarins from the Rare Actinomycete Catenulispora Acidiphila DSM 44928: Identification, Structure Elucidation, and Heterologous Production.

New Aminocoumarin Antibiotics Derived from 4-Hydroxycinnamic Acid Are Formed after Heterologous Expression of a Modified Clorobiocin Biosynthetic Gene Cluster

New Aminocoumarin Antibiotics from Genetically Engineered Streptomyces Strains.

In Vitro and in Vivo Production of New Aminocoumarins by A Combined Biochemical, Genetic, and Synthetic Approach

An Unusual Amide Synthetase (Coul) From The Coumermycin A(1) Biosynthetic Gene Cluster From Streptomyces Rishiriensis Dsm 40489

An Artificial Pathway to 3,4-Dihydroxybenzoic Acid Allows Generation of New Aminocoumarin Antibiotic Recognized by Catechol Transporters of E. coli

Genome Mining Enabled by Biosynthetic Characterization Uncovers a Class of Benzoxazolinate‐Containing Natural Products in Diverse Bacteria

Chapter 18 Aminocoumarins

Discovery and Biosynthesis of Cihanmycins Reveal Cytochrome P450-Catalyzed Intramolecular C-O Phenol Coupling Reactions

Metabolic Engineering of Aminocoumarins: Inactivation of the Methyltransferase Gene Clop and Generation of New Clorobiocin Derivatives in a Heterologous Host

Aminocoumarins: Mutasynthesis, Chemoenzymatic Synthesis, And Metabolic Engineering

Functional Analysis of Biosynthetic Genes of Aminocoumarins and Production of Hybrid Antibiotics

Carbamothioic S-acid Derivative and Kigamicins, the Activated Production of Silent Metabolites in Amycolatopsis Alba DSM 44262δabm9 Elicited by N-acetyl-D-glucosamine.

Activating and Attenuating the Amicoumacin Antibiotics

Assembly and Heterologous Expression of the Coumermycin A1 Gene Cluster and Production of New Derivatives by Genetic Engineering

Discovery of Ammosesters by Mining the Streptomyces Uncialis DCA2648 Genome Revealing New Insight into Ammosamide Biosynthesis

Improved mutasynthetic approaches for the production of modified aminocoumarin antibiotics.

Combinatorial Biosynthesis, Metabolic Engineering and Mutasynthesis for the Generation of New Aminocoumarin Antibiotics

Genome Mining of Cinnamoyl-Containing Nonribosomal Peptide Gene Clusters Directs the Production of Malacinnamycin.

Identification of the p-coumaric acid biosynthetic gene cluster in Kutzneria albida: insights into the diazotization-dependent deamination pathway

Molecular cloning and sequence analysis of the clorobiocin biosynthetic gene cluster: new insights into the biosynthesis of aminocoumarin antibiotics.